🇺🇸 FDA
Patent

US 6984402

Chrono delivery formulations and method of treating atrial fibrillation

expired A61KA61K31/554A61K9/2081

Quick answer

US patent 6984402 (Chrono delivery formulations and method of treating atrial fibrillation) held by Elite Laboratories, Inc. expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Elite Laboratories, Inc.
Grant date
Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/554, A61K9/2081, A61K9/5026, A61K9/5078